CRABP2 and ovarian carcinoma: Our results showed that the overall metabolic capacities, including the activity of oxidative phosphorylation and the tricarboxylic acid cycle, were higher in drug-resistance cells of SKOV3/DDP and A2780/DDP than those of parental cells, and CRABP2 upregulates these metabolic capacities in ovarian cancer.